PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
http://ww2.peerview.com
Gesamtlänge aller Episoden: 11 days 22 hours 24 minutes
Mitchell S. Cairo, MD - Journal Insight on VOD/SOS: Expert Views on New Evidence and Guidelines for Disease Management
Go online to www.peerview.com/KZZ860 to view the entire programme with slides.
Todd Dylan Levine, MD - Navigating the Patient Journey From CIDP Diagnosis Through Initial Treatment and Onto Long-Term Maintenance Therapy
Go online to www.peerviewpress.com/BVY860 to view the entire programme with slides.
Harry P. Erba, MD, PhD - A Master-Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options
Go online to www.peerviewpress.com/MJN860 to view the entire programme with slides.
Aaron Boster, MD - Potential Clinical Implications of the Latest Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis: A Recap From Paris
Go online to www.peerviewpress.com/SQK860 to view the entire programme with slides.
Daniel Pallin, MD, MPH - Oncologic Emergencies in the ED: Recognizing and Managing Adverse Reactions Associated With Modern Cancer Therapies—Essential Guidance for Emergency Medicine Specialists
Go online to www.peerviewpress.com/QUS860 to view the entire programme with slides.
Daniel J. DeAngelo, MD, PhD - Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes
Go online to www.peerviewpress.com/UHJ860 to view the entire programme with slides.
Naiyer Rizvi, MD - Addressing Unmet Needs in Lung Cancer With Rational Immunotherapy-Based Approaches: Evidence and Practicalities
Go online to www.peerviewpress.com/RZW860 to view the entire programme with slides.
Robin L. Jones, MD - Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes
Go online to www.peerviewpress.com/HVC860 to view the entire programme with slides.
David L. Rimm, MD, PhD - The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists
Go online to www.peerviewpress.com/HGJ860 to view the entire programme with slides.
Ghassan Abou-Alfa, MD, MBA - The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances
Go online to www.peerviewpress.com/EZN860 to view the entire programme with slides.